The global pharmaceutical market is worth approximately $934.8 billion and is estimated to reach over $1,170 billion in 2021, with locations spanning all continents. But with any global growth, so comes the growth of threats impacting the health of the industry.
According to a study conducted by Pharma IQ, only 53% of respondents in the pharmaceutical industry state that their organization has a brand protection strategy in place. The more shocking piece of this was that 26% don’t have a brand protection strategy and/or plans to put one in place at all.
Every year hundreds of thousands of people die due to counterfeit drugs. Some counterfeits even include things like printer ink, paint and arsenic. No doubt these have devastating consequences to the person ingesting them and end up being costly to the brand that has been replicated.
For pharmaceutical companies, any of the above issues can severely damage its brand reputation. In order to protect their brand, companies have to:
Register the Conference Now (at) 7th Seventh Brand Protection Excellence Forum (BPEF)
Write us to Connect
Follow us on Twitter
Connect us on Linkedin
Like us on Facebook
Follow us on Instagram
For More Events Click Here